Cargando…
TP53 transcription factor for the NEDD9/HEF1/Cas-L gene: potential targets in Non-Small Cell Lung Cancer treatment
Lung cancer is a serious public health problem. Although there has been significant progress in chemotherapy, non-small cell lung cancer is still resistant to current treatments, primarily because of the slow rate of cell development. It is thus important to find new molecules directed against targe...
Autores principales: | ROUSSEAU, Bénédicte, JACQUOT, Catherine, LE PALABE, Julie, MALLETER, Marine, TOMASONI, Christophe, BOUTARD, Tifenn, SAKANYAN, Vehary, ROUSSAKIS, Christos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443767/ https://www.ncbi.nlm.nih.gov/pubmed/26011298 http://dx.doi.org/10.1038/srep10356 |
Ejemplares similares
-
The WW-HECT protein Smurf2 interacts with the Docking Protein NEDD9/HEF1 for Aurora A activation
por: Moore, Finola E, et al.
Publicado: (2010) -
Activation of EGFR by small compounds through coupling the generation of hydrogen peroxide to stable dimerization of Cu/Zn SOD1
por: Sakanyan, Vehary, et al.
Publicado: (2016) -
Screening and discovery of nitro-benzoxadiazole compounds activating epidermal growth factor receptor (EGFR) in cancer cells
por: Sakanyan, Vehary, et al.
Publicado: (2014) -
Reactive Chemicals and Electrophilic Stress in Cancer: A Minireview
por: Sakanyan, Vehary
Publicado: (2018) -
Direct interaction between Smad3, APC10, CDH1 and HEF1 in proteasomal degradation of HEF1
por: Nourry, Claire, et al.
Publicado: (2004)